During the past decade, Guangdong 999 Brain Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guangdong 999 Brain Hospital" #1 sponsor was "Guangdong 999 Brain Hospital" with 3 trials, followed by "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine" with 2 trials sponsored, "Hong Yang" with 1 trials sponsored, "Huiqiang Huang" with 1 trials sponsored and "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guangdong 999 Brain Hospital" #1 collaborator was "Beijing Tricision Biotherapeutics Inc" with 3 trials as a collaborator, "Jinan University Guangzhou" with 3 trials as a collaborator, "Trinomab Biotech Co., Ltd." with 3 trials as a collaborator, "Guangdong 999 Brain Hospital" with 2 trials as a collaborator and "CNOG-MC001 Collaborative Group" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Guangdong 999 Brain Hospital" are "Glioblastoma" (2 trials), "Benign Brain Tumor" (1 trials), "Blood Pressure Variability" (1 trials), "Brain Cancer" (1 trials) and "Duration of ICU Treatment and Mechanical Ventilation" (1 trials). Many other conditions were trialed in "Guangdong 999 Brain Hospital" in a lesser frequency.

Most popular intervention types in "Guangdong 999 Brain Hospital" are "Biological" (3 trials), "Drug" (2 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Personalized cellular vaccine" (3 trials), "Analgesia-first minimal sedation" (1 trials), "Anisodine Hydrobromide" (1 trials), "Anisodine Hydrobromide placebo" (1 trials) and "Antihypertensive treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guangdong 999 Brain Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Guangdong 999 Brain Hospital". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Guangdong 999 Brain Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guangdong 999 Brain Hospital, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".